| World Health Organization classification of tumours DM Christopher Pathology & Genetic: Tumours of Soft Tissue and Bone, 2000 | 4978* | 2000 |
| WHO classification of tumor CDM Fletcher Pathology and Genetics of Tumor of Soft Tissue and Bone 427, 2002 | 3459 | 2002 |
| Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial J Verweij, PG Casali, J Zalcberg, A LeCesne, P Reichardt, JY Blay, ... The Lancet 364 (9440), 1127-1134, 2004 | 1838 | 2004 |
| Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO JY Blay, S Bonvalot, P Casali, H Choi, M Debiec-Richter, AP Dei Tos, ... Annals of Oncology 16 (4), 566-578, 2005 | 946 | 2005 |
| Sarcoma derived from cultured mesenchymal stem cells J Tolar, AJ Nauta, MJ Osborn, A Panoskaltsis Mortari, RT McElmurry, ... Stem cells 25 (2), 371-379, 2007 | 737 | 2007 |
| IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours MF Amary, K Bacsi, F Maggiani, S Damato, D Halai, F Berisha, R Pollock, ... The Journal of pathology 224 (3), 334-343, 2011 | 730 | 2011 |
| Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial I Judson, J Verweij, H Gelderblom, JT Hartmann, P Schöffski, JY Blay, ... The lancet oncology 15 (4), 415-423, 2014 | 562 | 2014 |
| The clinical approach towards chondrosarcoma H Gelderblom, PCW Hogendoorn, SD Dijkstra, CS Van Rijswijk, AD Krol, ... The oncologist 13 (3), 320-329, 2008 | 562 | 2008 |
| Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas I Ray-Coquard, C Cropet, M Van Glabbeke, C Sebban, A Le Cesne, ... Cancer research 69 (13), 5383-5391, 2009 | 480 | 2009 |
| Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are … J Verweij, A van Oosterom, JY Blay, I Judson, S Rodenhuis, ... European Journal of Cancer 39 (14), 2006-2011, 2003 | 461 | 2003 |
| Langerhans cell histiocytosis RM Egeler, GJ D'Angio The Journal of pediatrics 127 (1), 1-11, 1995 | 401 | 1995 |
| Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study WG Goettsch, SD Bos, N Breekveldt-Postma, M Casparie, RMC Herings, ... European journal of cancer 41 (18), 2868-2872, 2005 | 375 | 2005 |
| Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? JK Anninga, H Gelderblom, M Fiocco, JR Kroep, AHM Taminiau, ... European journal of cancer 47 (16), 2431-2445, 2011 | 365 | 2011 |
| The histopathological differential diagnosis of gastrointestinal stromal tumours JFG van Roggen, MLF Van Velthuysen, PCW Hogendoorn Journal of clinical pathology 54 (2), 96-102, 2001 | 361 | 2001 |
| Multiple osteochondromas JVMG Bovée Orphanet journal of rare diseases 3 (1), 1-7, 2008 | 341 | 2008 |
| Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma … IJ Lewis, MA Nooij, J Whelan, MR Sydes, R Grimer, PCW Hogendoorn, ... Journal of the National Cancer Institute 99 (2), 112-128, 2007 | 339 | 2007 |
| Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and … M Van Glabbeke, J Verweij, PG Casali, A Le Cesne, P Hohenberger, ... Journal of Clinical Oncology 23 (24), 5795-5804, 2005 | 323 | 2005 |
| Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial PJ Woll, P Reichardt, A Le Cesne, S Bonvalot, A Azzarelli, HJ Hoekstra, ... The lancet oncology 13 (10), 1045-1054, 2012 | 321 | 2012 |
| Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2 AB Mohseny, K Szuhai, S Romeo, EP Buddingh, I Briaire‐de Bruijn, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 265 | 2009 |
| Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ESMO/European Sarcoma Network Working Group Annals of oncology: official journal of the European Society for Medical …, 2012 | 264 | 2012 |
